These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9314094)
1. Comments to consensus document. Once-daily dosing of aminoglycosides from N. Anaizi. A supplement to dosage and monitoring in critically ill patients. Reimann IR; Meier-Hellmann A; Reinhart K; Hoffmann A Int J Clin Pharmacol Ther; 1997 Sep; 35(9):397. PubMed ID: 9314094 [No Abstract] [Full Text] [Related]
2. Once-daily dosing of aminoglycosides. A consensus document. Anaizi N Int J Clin Pharmacol Ther; 1997 Jun; 35(6):223-6. PubMed ID: 9208335 [No Abstract] [Full Text] [Related]
3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
4. Optimizing use of aminoglycosides in the critically ill. Rea RS; Capitano B Semin Respir Crit Care Med; 2007 Dec; 28(6):596-603. PubMed ID: 18095223 [TBL] [Abstract][Full Text] [Related]
8. Single daily dosing of aminoglycosides--A community standard? Brown GH; Bertino JS; Rotschafer JC Clin Infect Dis; 2000 Mar; 30(3):440-1. PubMed ID: 10722425 [No Abstract] [Full Text] [Related]
9. Daily dosage of aminoglycosides. Urban AW; Craig WA Curr Clin Top Infect Dis; 1997; 17():236-55. PubMed ID: 9189668 [No Abstract] [Full Text] [Related]
10. Pharmacokinetic variability of extended interval tobramycin in burn patients. Bracco D; Landry C; Dubois MJ; Eggimann P Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988 [TBL] [Abstract][Full Text] [Related]
11. Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring. De Waele JJ; De Neve N Minerva Anestesiol; 2014 Oct; 80(10):1135-42. PubMed ID: 24326971 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients. Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366 [TBL] [Abstract][Full Text] [Related]
13. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration? Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898 [TBL] [Abstract][Full Text] [Related]
14. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective. Pea F; Poz D; Viale P; Pavan F; Furlanut M J Antimicrob Chemother; 2006 Aug; 58(2):380-6. PubMed ID: 16735422 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. Brink AJ; Richards GA; Schillack V; Kiem S; Schentag J Int J Antimicrob Agents; 2009 May; 33(5):432-6. PubMed ID: 19091521 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic issues for antibiotics in the critically ill patient. Roberts JA; Lipman J Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886 [TBL] [Abstract][Full Text] [Related]
17. [Aminoglycosides: once a day?]. Fantin B Rev Prat; 1998 Feb; 48(4):353-5. PubMed ID: 9781087 [No Abstract] [Full Text] [Related]
18. Once daily dosing of aminoglycosides. Denaro C Aust N Z J Med; 1994 Dec; 24(6):730-1. PubMed ID: 7717932 [No Abstract] [Full Text] [Related]